Enhanced alveolar cell luminol-dependent chemiluminescence in asthma.
暂无分享,去创建一个
J. Bousquet | P. Chanez | P. Godard | A. Crastes de Paulet | M. Damon | F. Michel | M. Cluzel | Philippe Godard | J. Bousquet | A. D. Paulet
[1] W. Busse,et al. Enhanced eosinophil luminol-dependent chemiluminescence in allergic rhinitis. , 1986, The Journal of allergy and clinical immunology.
[2] W. Burman,et al. Oxidant-mediated ciliary dysfunction. Possible role in airway disease. , 1986, Chest.
[3] H. Sluiter,et al. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. , 1985, The American review of respiratory disease.
[4] P. Godard,et al. Decreased suppressor cell activity of alveolar macrophages in bronchial asthma. , 2015, The American review of respiratory disease.
[5] K. Austen,et al. The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology. , 1984, The Journal of clinical investigation.
[6] B. Babior. The respiratory burst of phagocytes. , 1984, The Journal of clinical investigation.
[7] K. Yamamoto,et al. Dissociation of phagocytosis from stimulation of the oxidative metabolic burst in macrophages , 1984, The Journal of experimental medicine.
[8] C. Cochrane,et al. Biochemical factors in pulmonary inflammatory disease. , 1983, Federation proceedings.
[9] A. Greening,et al. Extracellular release of hydrogen peroxide by human alveolar macrophages: the relationship to cigarette smoking and lower respiratory tract infections. , 1983, Clinical science.
[10] B. Samuelsson. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. , 1983, Science.
[11] A. Capron,et al. Involvement of immunoglobulin E in the secretory processes of alveolar macrophages from asthmatic patients. , 1983, The Journal of clinical investigation.
[12] N. Pawlowski,et al. Human alveolar macrophages produce leukotriene B4. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[13] P. Godard,et al. Functional assessment of alveolar macrophages: comparison of cells from asthmatics and normal subjects. , 1982, The Journal of allergy and clinical immunology.
[14] J. Bousquet,et al. Total Serum IgE Concentrations in Adolescents and Adults Using the Phadebas IgE PRIST® Technique , 1982, Allergy.
[15] C. Nathan. Secretion of oxygen intermediates: role in effector functions of activated macrophages. , 1982, Federation proceedings.
[16] A. P. Autor. Pathology of oxygen , 1982 .
[17] P. Cole,et al. Investigation of alveolar macrophage function using lucigenin-dependent chemiluminescence. , 1981, Thorax.
[18] G. Solley,et al. Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma. , 1981, Mayo Clinic proceedings.
[19] P. Cole,et al. Human bronchoalveolar lavage cells and luminol-dependent chemiluminescence. , 1981, Journal of clinical pathology.
[20] B Chance,et al. Low level chemiluminescence of alveolar macrophages , 1981, FEBS letters.
[21] S. Kong,et al. The relative effectiveness of .OH, H2O2, O2-, and reducing free radicals in causing damage to biomembranes. A study of radiation damage to erythrocyte ghosts using selective free radical scavengers. , 1981, Biochimica et biophysica acta.
[22] K Aas,et al. Heterogeneity of Bronchial Asthma , 1981, Allergy.
[23] Bengt Samuelsson,et al. Leukotrienes are potent constrictors of human bronchi , 1980, Nature.
[24] E. Pick,et al. A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. , 1980, Journal of immunological methods.
[25] H. Forman,et al. Rat alveolar macrophages require NADPH for superoxide production in the respiratory burst. Effect of NADPH depletion by paraquat. , 1980, The Journal of biological chemistry.
[26] S. Klebanoff. Oxygen metabolism and the toxic properties of phagocytes. , 1980, Annals of internal medicine.
[27] M. Daha,et al. The effect of lidocaine on the processing of soluble immune aggregates and immune complexes by peritoneal macrophages. , 1980, Immunology.
[28] A. Sagone,et al. Characterization of the metabolic responses of the human pulmonary alveolar macrophage. , 1980, Journal of the Reticuloendothelial Society.
[29] A. Michaels,et al. Creatinine: an inadequate filtration marker in glomerular diseases. , 1980, The American journal of medicine.
[30] A. Capron,et al. Enzyme release and superoxide anion production by human alveolar macrophages stimulated with immunoglobulin E. , 1980, Clinical and experimental immunology.
[31] T. Yamaguchi,et al. Comparative studies on alveolar macrophages and polymorphonuclear leukocytes. I. H2O2 and O2- generation by rabbit alveolar macrophages. , 1980, Journal of biochemistry.
[32] J. McCord,et al. Free Radicals as Mediators of Tissue Injury , 1980 .
[33] I. Fridovich,et al. Superoxide radical and superoxide dismutases: threat and defense. , 1980, Acta physiologica Scandinavica. Supplementum.
[34] J. V. Bannister,et al. Biological and clinical aspects of superoxide and superoxide dismutase , 1980 .
[35] W. Hsueh. Prostaglandin biosynthesis in pulmonary macrophages. , 1979, The American journal of pathology.
[36] J. Allen,et al. Oxidative metabolic responses of rabbit pulmonary alveolar macrophages. , 1979, Blood.
[37] J. White,et al. Comparison of the metabolism of alveolar macrophages from humans, rats, and rabbits: phorbol myristate acetate. , 1978, The Journal of laboratory and clinical medicine.
[38] Z. Cohn,et al. Increased superoxide anion production by immunologically activated and chemically elicited macrophages , 1978, The Journal of experimental medicine.
[39] H. Jacob,et al. Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage. , 1978, The Journal of clinical investigation.
[40] W. Biggar,et al. Bactericidal mechanisms in rabbit alveolar macrophages: evidence against peroxidase and hydrogen peroxide bactericidal mechanisms , 1976, Infection and immunity.
[41] C. McCall,et al. The generation of superoxide anion by various types of phagocyte. , 1975, The Journal of infectious diseases.